id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-303942-77nbi3ws	Segal, Jonathan P	Prevention of COVID-19 in patients with IBD	2020-05-20		.txt	text/plain	632	39	53	We read with interest the Correspondence from Ping An and colleagues 1 describing their efforts to prevent coronavirus disease 2019 in patients with inflammatory bowel disease (IBD) in Wuhan, China. Indeed, the National Health Service, in conjunction with the British Society of Gastroenterology (BSG), relied on individual health-care trusts to highlight patients at high risk with IBD so advice could be delivered by post regarding shielding and stringent physical distancing. BSG guidance suggests that patients should continue on their current medications, including infliximab, as active disease remains the biggest risk to a patient with IBD. As further evidence accumulates, our understanding of COVID-19-related risks in IBD populations globally will improve. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China BSG COVID-19 Guidance on IBD patient risk groups British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic	./cache/cord-303942-77nbi3ws.txt	./txt/cord-303942-77nbi3ws.txt